alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
H. Res. 595 

In the House of Representatives, U. S., 

November 1, 2017. 

Resolved, That at any time after adoption of this resolution the Speaker may, pursuant to clause 2(b) of rule XVIII, 

declare the House resolved into the Committee of the Whole 

House on the state of the Union for consideration of the bill 

(H.R. 2936) to expedite under the National Environmental 

Policy Act of 1969 and improve forest management activities 

on National Forest System lands, on public lands under the 

jurisdiction of the Bureau of Land Management, and on 

Tribal lands to return resilience to overgrown, fire-prone forested lands, and for other purposes. The first reading of the 

bill shall be dispensed with. All points of order against consideration of the bill are waived. General debate shall be confined to the bill and amendments specified in this resolution 

and shall not exceed one hour equally divided among and controlled by the chair and ranking minority member of the 

Committee on Agriculture and the chair and ranking minority member of the Committee on Natural Resources. After 

general debate the bill shall be considered for amendment 
2 

•HRES 595 EH 

under the five-minute rule. In lieu of the amendments in the 

nature of a substitute recommended by the Committees on 

Agriculture and Natural Resources now printed in the bill, it 

shall be in order to consider as an original bill for the purpose of amendment under the five-minute rule an amendment 

in the nature of a substitute consisting of the text of Rules 

Committee Print 115–36. That amendment in the nature of 

a substitute shall be considered as read. All points of order 

against that amendment in the nature of a substitute are 

waived. No amendment to that amendment in the nature of 

a substitute shall be in order except those printed in the report of the Committee on Rules accompanying this resolution. 

Each such amendment may be offered only in the order 

printed in the report, may be offered only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the report equally divided 

and controlled by the proponent and an opponent, shall not 

be subject to amendment, and shall not be subject to a demand for division of the question in the House or in the 

Committee of the Whole. All points of order against such 

amendments are waived. At the conclusion of consideration of 

the bill for amendment the Committee shall rise and report 

the bill to the House with such amendments as may have 

been adopted. Any Member may demand a separate vote in 

the House on any amendment adopted in the Committee of 
3 

•HRES 595 EH 

the Whole to the bill or to the amendment in the nature of 

a substitute made in order as original text. The previous 

question shall be considered as ordered on the bill and 

amendments thereto to final passage without intervening motion except one motion to recommit with or without instructions. 

Attest: 

Clerk.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          APR-30-1997
<PERIOD-END>                               JAN-31-1997
<CASH>                                           3,899
<SECURITIES>                                         0
<RECEIVABLES>                                  371,459
<ALLOWANCES>                                         0
<INVENTORY>                                    145,806
<CURRENT-ASSETS>                               542,879
<PP&E>                                       6,679,513
<DEPRECIATION>                               1,230,844
<TOTAL-ASSETS>                               6,023,821
<CURRENT-LIABILITIES>                        2,023,882
<BONDS>                                      2,120,918
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    23,859,835
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 6,023,821
<SALES>                                              0
<TOTAL-REVENUES>                             1,413,789
<CGS>                                                0
<TOTAL-COSTS>                                1,015,251
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             166,505
<INCOME-PRETAX>                            (1,793,544)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,793,544)
<EPS-PRIMARY>                                    (.12)
<EPS-DILUTED>                                    (.12)
        

</TABLE>
# C_2014329EN.01001502.xml

| 22.9.2014 | EN | Official Journal of the European Union | C 329/15 |
| --- | --- | --- | --- |

22.9.2014

EN

Official Journal of the European Union

C 329/15

---

Order of the President of the General Court of 10 June 2014 — Georgsmarienhütte v Commission

(Case T-176/14 R)

((Interim measures - State aid - National promotion of electricity production from a renewable source - Commission decision to open formal investigation procedure in respect of State aid - Application for suspension of operation of a measure - Urgency - Fumus boni juris))

2014/C 329/20

Language of the case: German

Parties

Parties

Applicant: Gerorgsmarienhütte GmbH (Georgsmarienhütte, Germany) (represented by: H. Hofler, C. Kahle and V. Winkler, lawyers)

Applicant:

Defendant: European Commission (represented by: T. Maxian Rusche and R. Sauer, Agents)

Defendant:

Re:

Re:

Application for suspension of the legal effects of the decision by which the Commission opened a formal investigation procedure in respect of State aid concerning the German law on renewable energy.

Operative part of the order

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | The judgment in Case T-176/14 R Gerorgsmarienhütte v Commission is set aside |
| --- | --- |

2.

The judgment in Case T-176/14 R Gerorgsmarienhütte v Commission is set aside

| 3. | Costs are reserved. |
| --- | --- |

3.

Costs are reserved.

---
<PAGE>
 
                                                                    EXHIBIT 23.1
                                                                                

                   Consent of Independent Public Accountants
                   -----------------------------------------


To Astea International Inc.:


As independent public accountants, we hereby consent to the incorporation of our
report, included in this Form 10-K, into the Company's previously filed Form S-8
Registration Statement File Nos. 333-97064, 333-33825, 333-34865 and 333-61981
and Form S-3 Registration Statement File Nos. 333-11949 and 333-17459.



                                 /s/Arthur Andersen LLP
 


Philadelphia, PA
March 26, 1999


                                      57
Exhibit 31.1








I, Mary G. Merritt, certify that:





1. I have reviewed this annual report on Form 10-K of Preferred Voice, Inc.;





2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;





3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report.





4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and I have:





a. designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this annual report is being prepared;





b. evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the "Evaluation Date"); and





c. presented in this annual report my conclusions about the effectiveness of the disclosure controls and procedures based on my evaluation as of the Evaluation Date;





5. I have disclosed, based on our most recent evaluation, to the registrant's auditors and the board of directors (or persons performing the equivalent function):





a. all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and





b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and





6. I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.






June 21, 2010
By:
/s/ Mary G. MerrittMary G. MerrittChief Financial Officer(Principal Executive Officerand  Principal Financial Officer)
§ 520.2345f Tetracycline phosphate complex and sodium novobiocin capsules. ( a ) *Specifications.* Each capsule contains the equivalent of 60 milligrams of tetracycline hydrochloride and 60 milligrams of novobiocin.
( b ) *Sponsor.* No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* 10 milligrams of each antibiotic per pound of body weight (1 capsule for each 6 pounds) every 12 hours.
( 2 ) *Indications for use.* Treatment of acute or chronic canine respiratory infections such as tonsillitis, bronchitis, and tracheobronchitis when caused by pathogens susceptible to tetracycline and/or novobiocin, such as *Staphylococcus* spp. and *Escherichia coli.*
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[57 FR 37329, Aug. 18, 1992, as amended at 79 FR 28831, May 20, 2014]
#### Gualtieri and Johnson Construction Company, Inc. *v.*Town Plan and Zoning Commission of the Town of Farmington

*Palmer S. McGee, Jr.,*for the appellant (defendant).

Argued March 4

decided March 5, 1969

The motion by the defendant to have the judgment of the Court of Common Pleas in Hartford County set aside, and the appeal from the defendant’s decision dismissed, is denied.
## Docket No. FAA **- 20**  **12 -**  **0 192** 

**Contacts.** With whom outside the FAA has this proposal been discussed?

Organization Person Contacted Date Response National Business Aircraft Association Eli Cotti 10/14 /11 Regional Airline Association 10/14/1 1 Aircraft Owners & Pilots Association Robert Hackman 10/14/11

AT A Joe White 10/14/11
##### 



Exhibit 32.1
 CERTIFICATION PURSUANT TO RULE 13a-14(b) OF
THE SECURITIES EXCHANGE ACT OF 1934
  (1)
    
    the Report fully complies with the requirements of Section 13(a) of the Securities
Exchange Act of 1934, as amended; and(2)
    
    the information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 November 9, 2007
    By:
    /s/ Charles F. ChampionCharles F. ChampionPresident and Chief Executive OfficerNovember 9, 2007
    By:
    /s/ James A. BurkJames A. BurkChief Financial Officer
# C_2015046EN.01002102.xml

| 9.2.2015 | EN | Official Journal of the European Union | C 46/21 |
| --- | --- | --- | --- |

9.2.2015

EN

Official Journal of the European Union

C 46/21

---

Request for a preliminary ruling from the Tribunalul Sibiu (Romania) lodged on 6 November 2014 — The Romanian State v Tamara Văraru and Consiliul Național pentru Combaterea Discriminării

(Case C-496/14)

(2015/C 046/27)

Language of the case: Romanian

Referring court

Referring court

Tribunalul Sibiu

Parties to the main proceedings

Parties to the main proceedings

Appellant: The Romanian State, represented by the Administrația Județeană a Finanțelor Publice Sibiu in the name and on behalf of the Ministerul Finanțelor Publice

Appellant:

Respondents: Tamara Văraru and Consiliul Național pentru Combaterea Discriminării

Respondents:

Question referred

Question referred

Are Article 6 of the Treaty on European Union, Articles 20, 21(1), 24(1), 34(1) and (2) and 52 of the Charter of Fundamental Rights of the European Union and Article 4 of Regulation (EC) No 883/2004 on the coordination of social security systems (1) to be interpreted as precluding national legislation, such as Ordonanță de Urgență a Guvernului No 111/2010, which provides that the second-born, third-born and so on of multiple births, the first-born of multiple births and children born as single births are to be treated differently?

1

---

(1)  Regulation (EC) No 883/2004 of the European Parliament and of the Council of 29 April 2004 on the coordination of social security systems (Text with relevance for the EEA and for Switzerland) (OJ 2004 L 166, p. 1).

1

---
DISMISS and Opinion Filed December 13, 2022 

# S

In The 

### Court of Appeals Fifth District of Texas at Dallas No. 05-22-00873-CV DAVID LEE DANIELS III, Appellant V. KATINA SNOW, CHILD SUPPOR T AGENCY, ATWORK GROUP, NANCY DELGADO, JAZMINE W ELLS CASTILLO, MARITZA DE JESUS, MARIA CARRILLO, AMANDA ALVEY, AND KR YOUNG STAFFING TX557, Appellees On Appeal from the 134th Judicial District Court Dallas County, Texas Trial Court Cause No. DC-22-05096 MEMORANDUM OPINION Before Chief Justice Burns, Justi ce Molberg, and Justice Goldstein Opinion by Chief Justice Burns We questioned our jurisdiction over this appeal from the trial court’s August 18, 2022 dismissal order as it did not appear the order disposed of all parties and claims or that the order was otherwise appealable. See Jack B. Ang lin Co., Inc. v. Tipps , 842 S.W.2d 266, 272 (Tex. 1992) (app eal may only be taken from final judgments that dispose of all parties and cl aims or interlocutory orders authorized by statute). As reflected in the record, appellant filed the underlying suit against Katina Snow, Child Support Agency, AtWork Group, Na ncy Delgado, Jazmine–2– Wells Castillo, Maritza De Jesus, Maria Carrillo, Amanda Alve y, and KR Young Staffing TX557. The appealed order di smissed the claims against KR Young Staffing, AtWork Group, Delgado, Cas tillo, De Jesus, Carrillo, and Alvey by granting their Rule 91a motion, see T EX

. R. C IV

. P. 91a (concerning baseless causes of action), but did not address the clai ms against Snow and the Child Support Agency. Although we directed appellant to file a letter brief addressing our concern and cautioned appellant that failure to comply could result in the appeal being dismissed, see T EX

. R. A PP

. P. 42.3(a),(c), more than te n days have passed and appellant has not complied. Accordingly, on the record before us, we dismiss the appeal. See id. 42.3(a); see also Koenig v. Blaylock , 497 S.W.3d 595, 598 n.4 (Tex. App.—Austin 2016, pet. deni ed) (noting no statute authorizes interlocutory appeal from order denying Rule 91a motion).

220873F.P05 /Robert D. Bu r ns, III / ROBERT D. BURNS, III CHIEF JUSTICE–3– 

# S

Court of Appeals Fifth District of Texas at Dallas JUDGMENT
DAVID LEE DANIELS III, Appellant

No. 05-22-00873-CV V. KATINA SNOW, CHILD SUPPORT AGENCY, ATWORK GROUP, NANCY DELGADO, JAZMINE WELLS CASTILLO, MARITZE DE JESUS, MARIA CARRILLO, AMANDA ALVEY, AND KR YOUNG STAFFING TX557, Appellees On Appeal from the 134th Judicial District Court, Dallas County, Texas Trial Court Cause No. DC-22-05096. Opinion delivered by Chief Justice Burns, Justices Molberg and Goldstein participating.

In accordance with this Court’ s opinion of this date, we DISMISS the appeal.
Judgment entered December 13, 2022.
#### § 607.21 Times for establishment registration and blood product listing.

The owner or operator of an establishment entering into an operation defined in § 607.3(d) shall register such establishment within 5 days after the beginning of such operation and submit a list of every blood product in commercial distribution at the time. If the owner or operator of the establishment has not previously entered into such operation (defined in § 607.3(d) of this chapter) for which a license is required, registration shall follow within 5 days after the submission of a biologics license application in order to manufacture blood products. Owners or operators of all establishments so engaged must register annually between October 1 and December 31 and must update their blood product listing every June and December.

[40 FR 52788, Nov. 12, 1975, as amended at 64 FR 56453, Oct. 20, 1999; 81 FR 60222, Aug. 31, 2016]
§ 82.2051 Lakes (Ext. D&C). ( a ) ( 1 ) *General.* Any lake made by extending on a substratum of alumina, blanc fixe, gloss white, clay, titanium dioxide, zinc oxide, talc, rosin, aluminum benzoate, calcium carbonate, or on any combination of two or more of these ( i ) one of the straight colors hereinbefore listed in this subpart, which color is a salt in which is combined the basic radical sodium, potassium, barium, or calcium; or
( ii ) a salt prepared from one of the straight colors hereinbefore listed in this subpart by combining such color with the basic radical sodium, potassium, aluminum, barium, calcium, strontium, or zirconium.
( 2 ) *Specifications.* Ether extracts, not more than 0.5 percent. Soluble chlorides and sulfates (as sodium salts), not more than 3.0 percent. Intermediates, not more than 0.2 percent.
( b ) Each lake made as prescribed in paragraph (a) of this section shall be considered to be a straight color and to be listed therein under the name which is formed as follows: ( 1 ) The listed name of the color from which the lake is prepared;
( 2 ) The name of the basic radical combined in such color; and
( 3 ) The word “Lake.” (For example, the name of a lake prepared by extending the color Ext. D&C Yellow No. 2 upon a substratum is “Ext. D&C Yellow No. 2—Calcium Lake,” and a lake prepared by extending the barium salt prepared from Ext. D&C Red No. 2 upon the substratum is “Ext. D&C Red No. 2—Barium Lake.”)
<PAGE>



                                                                  EXHIBIT 8.1



                              LIST OF SUBSIDIARIES

         Protherics PLC acts as the holding company of a group consisting of its
directly and indirectly held subsidiaries. Protherics PLC has the following
principal subsidiaries:


<TABLE>
<CAPTION>

DIRECT HOLDINGS                            % HELD     STATUS      COUNTRY OF INCORPORATION
---------------                            ------     ------      ------------------------
<S>                                        <C>        <C>         <C>
Protherics Medicines Development Limited     100      trading     England and Wales
Protherics Inc.                              100      trading     U.S.A. (Delaware)
Enact Pharma Limited                         100      trading     England and Wales
Proteus Biotechnology Limited                100      dormant     England and Wales
Genethics Limited                             76      dormant     England and Wales

INDIRECT HOLDINGS
-----------------
Protherics UK Limited                        100      trading     England and Wales
Protherics Australasia pty Limited           100      trading     Australia
Protherics Utah Inc.                         100      trading     U.S.A. (Delaware)
Protherics Services pty Limited              100      dormant     Australia
Kymed GB Limited                             100      dormant     England and Wales
Enzacta R&D Limited                           99.8    dormant     England and Wales
DeMontford Biopharma Limited                 100      dormant     England and Wales
Enzacta Limited                               99.8    dormant     England and Wales
TAb (Wales) Limited                          100      dormant     England and Wales
TAb (London) Limited                         100      dormant     England and Wales
Polyclonal Antibodies Limited                100      dormant     England and Wales

</TABLE>
I 

118TH CONGRESS 

2D SESSION H. R. 7665 

To amend title XVIII of the Social Security Act to improve the way beneficiaries are assigned under the Medicare shared savings program by 

also basing such assignment on primary care services furnished by nurse 

practitioners, physician assistants, and clinical nurse specialists. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 13, 2024 

Mr. KILMER (for himself, Mr. SMITH of Nebraska, Ms. DELBENE, and Mr. 

GALLAGHER) introduced the following bill; which was referred to the 

Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the 

Speaker, in each case for consideration of such provisions as fall within 

the jurisdiction of the committee concerned 

A BILL 

To amend title XVIII of the Social Security Act to improve 

the way beneficiaries are assigned under the Medicare 

shared savings program by also basing such assignment 

on primary care services furnished by nurse practitioners, 

physician assistants, and clinical nurse specialists. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘ACO Assignment Im5 provement Act of 2024’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7665 IH

1 SEC. 2. IMPROVEMENTS TO THE ASSIGNMENT OF BENE2 FICIARIES UNDER THE MEDICARE SHARED 

3 SAVINGS PROGRAM. 

4 Section 1899(c)(1) of the Social Security Act (42 

5 U.S.C. 1395jjj(c)(1)) is amended— 

6 (1) in subparagraph (A), by striking ‘‘and’’ at 

7 the end; 

8 (2) in subparagraph (B), by striking the period 

9 at the end and inserting ‘‘; and’’; and 

10 (3) by adding at the end the following new sub11 paragraph: 

12 ‘‘(C) in the case of performance years be13 ginning on or after January 1, 2025, primary 

14 care services provided under this title by an 

15 ACO professional described in subsection 

16 (h)(1)(B).’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
§ 801.18 Format of dates provided on a medical device label. ( a ) *In general.* Whenever the label of a medical device includes a printed expiration date, date of manufacture, or any other date intended to be brought to the attention of the user of the device, the date must be presented in the following format: The year, using four digits; followed by the month, using two digits; followed by the day, using two digits; each separated by hyphens. For example, January 2, 2014, must be presented as 2014-01-02.
( b ) *Exceptions.* ( 1 ) A combination product that properly bears a National Drug Code (NDC) number is not subject to the requirements of paragraph (a) of this section.
( 2 ) If the device is an electronic product to which a standard is applicable under subchapter J of this chapter, Radiological Health, the date of manufacture shall be presented as required by § 1010.3(a)(2)(ii) of this chapter.
[78 FR 58818, Sept. 24, 2013]
#### § 1250.96 Rodent control.

Vessels shall be maintained free of rodent infestation through the use of traps, poisons, and other generally accepted methods of rodent control.